# Social Determinants and a Diabetes Prevention Program Tailored for African Americans

Study · id `cardio:ct-nct05301413` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05301413](<https://clinicaltrials.gov/study/NCT05301413>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05301413

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 360 participants.

## Technical summary

Registry record NCT05301413. Randomized; no masking; primary purpose prevention. Start 2022-07-20 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 360 participants (planned count; ClinicalTrials.gov record NCT05301413, source copy `cardio:ctgov-nct05301413-2025-05-25`, retrieved 2026-11-18)
- Started: 2022-07-20 (actual) (ClinicalTrials.gov record NCT05301413, source copy `cardio:ctgov-nct05301413-2025-05-25`, retrieved 2026-11-18)
- Primary completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT05301413, source copy `cardio:ctgov-nct05301413-2025-05-25`, retrieved 2026-11-18)
- Completion: 2026-02-28 (anticipated) (ClinicalTrials.gov record NCT05301413, source copy `cardio:ctgov-nct05301413-2025-05-25`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05301413, source copy `cardio:ctgov-nct05301413-2025-05-25`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05301413-2025-05-25`, retrieved 2026-11-18)

## The registry's words

- Brief title: Social Determinants and a Diabetes Prevention Program Tailored for African Americans
- Acronym: FIT4ALL
- Condition: PreDiabetes
- Condition: Overweight and Obesity
- Intervention (Behavioral): Culturally Tailored Diabetes Prevention Program
- Intervention (Behavioral): Culturally Tailored DPP Enhanced with Socioeconomic Supports
- Intervention (Behavioral): Diabetes Prevention Program
- Lead sponsor: University of Missouri, Kansas City
- Lead sponsor class: OTHER
- Collaborator: University of Massachusetts, Amherst
- Collaborator class: OTHER
- Collaborator: University of Kansas
- Collaborator class: OTHER
- Collaborator: Children's Mercy Hospital Kansas City
- Collaborator class: OTHER
- Collaborator: University Health
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry lists this organization as a collaborator: University of Kansas (`cardio:org-university-of-kansas`)

## Provenance

Content hash: e03d811c9ebcc8f339e8b6aa7fe0534b0377ab50fb640993c5e52688130ede33
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
